MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 57 filers reported holding MUSTANG BIO INC in Q3 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $37,000 | -42.2% | 36,963 | -4.5% | 0.00% | – |
| Q4 2021 | $64,000 | -37.3% | 38,698 | +1.6% | 0.00% | -100.0% |
| Q3 2021 | $102,000 | -20.9% | 38,092 | -2.3% | 0.00% | – |
| Q2 2021 | $129,000 | +33.0% | 38,998 | +32.9% | 0.00% | – |
| Q1 2021 | $97,000 | -12.6% | 29,345 | +0.3% | 0.00% | – |
| Q4 2020 | $111,000 | +105.6% | 29,268 | +70.9% | 0.00% | – |
| Q3 2020 | $54,000 | -3.6% | 17,128 | -2.2% | 0.00% | – |
| Q2 2020 | $56,000 | +27.3% | 17,519 | +6.3% | 0.00% | – |
| Q1 2020 | $44,000 | -38.0% | 16,480 | -5.5% | 0.00% | – |
| Q4 2019 | $71,000 | +24.6% | 17,432 | -0.8% | 0.00% | – |
| Q3 2019 | $57,000 | -12.3% | 17,578 | -0.7% | 0.00% | – |
| Q2 2019 | $65,000 | +85.7% | 17,701 | +72.0% | 0.00% | – |
| Q1 2019 | $35,000 | +12.9% | 10,294 | -3.1% | 0.00% | – |
| Q4 2018 | $31,000 | -51.6% | 10,628 | -0.8% | 0.00% | – |
| Q3 2018 | $64,000 | -14.7% | 10,710 | -1.3% | 0.00% | – |
| Q2 2018 | $75,000 | – | 10,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 125,000 | $336,000 | 0.45% |
| Spotlight Asset Group, Inc. | 305,312 | $821,000 | 0.41% |
| GSA CAPITAL PARTNERS LLP | 560,215 | $1,507,000 | 0.15% |
| Ikarian Capital, LLC | 506,033 | $1,360,000 | 0.10% |
| EMFO, LLC | 31,000 | $83,000 | 0.07% |
| Bridgewater Advisors Inc. | 45,000 | $121,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 253,275 | $682,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 294,300 | $792,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 1,235,200 | $3,323,000 | 0.01% |
| Cypress Capital Management LLC (WY) | 2,950 | $8,000 | 0.01% |